Edition:
United Kingdom

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

5.95USD
15 Dec 2017
Change (% chg)

$0.02 (+0.34%)
Prev Close
$5.93
Open
$5.93
Day's High
$6.07
Day's Low
$5.90
Volume
243,934
Avg. Vol
84,048
52-wk High
$6.65
52-wk Low
$1.35

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

James Geraghty

62 2017 Chairman of the Board

Stephen Yoder

39 2014 President, Chief Executive Officer, Director

Lance Thibault

50 2017 Acting Chief Financial Officer

Claude Knopf

2016 Senior Vice President, Chief Business Officer

Louis Matis

54 2015 Senior Vice President and Chief Development Officer